Mptens as modifiers of the pten/igf pathway and methods of use

C - Chemistry – Metallurgy – 12 – Q

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12Q 1/00 (2006.01) C07H 21/04 (2006.01) C12Q 1/42 (2006.01)

Patent

CA 2527853

Human MPTEN genes are identified as modulators of the PTEN/IGF pathway, and thus are therapeutic targets for disorders associated with defective PTEN/IGF function. Methods for identifying modulators of PTEN/IGF, comprising screening for agents that modulate the activity of MPTEN are provided.

Selon l'invention, des gènes MPTEN humains ont été identifiés en tant que modulateurs du passage PTEN/IGF, et sont ainsi des cibles thérapeutiques pour des troubles liés à une déficience de la fonction PTEN/IGF. L'invention a également pour objet des procédés pour identifier des modulateurs de PTEN/IGF, comprenant des agents qui modulent l'activité de MPTEN.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Mptens as modifiers of the pten/igf pathway and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Mptens as modifiers of the pten/igf pathway and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mptens as modifiers of the pten/igf pathway and methods of use will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1876160

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.